Division 5.1.1 F1F2 United Kingdom Original text. Later amendments are not shown. The specific requirements in this section of Part IV are additional requirements to those set in Module 5 in Part I of this Annex. Annotations Textual amendments F1 Substituted by Commission directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (Text with EEA relevance). F2 Substituted by Commission Directive 2009/120/EC of 14 September 2009 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products (Text with EEA relevance). ← Division 5.1 Division 5.1.1 Division 5.1.2 →